Your browser doesn't support javascript.
Unusual SARS-CoV-2 intrahost diversity reveals lineage superinfection.
Dezordi, Filipe Zimmer; Resende, Paola Cristina; Naveca, Felipe Gomes; do Nascimento, Valdinete Alves; de Souza, Victor Costa; Dias Paixão, Anna Carolina; Appolinario, Luciana; Lopes, Renata Serrano; da Fonseca Mendonça, Ana Carolina; Barreto da Rocha, Alice Sampaio; Martins Venas, Taina Moreira; Pereira, Elisa Cavalcante; Paiva, Marcelo Henrique Santos; Docena, Cassia; Bezerra, Matheus Filgueira; Machado, Laís Ceschini; Salvato, Richard Steiner; Gregianini, Tatiana Schäffer; Martins, Leticia Garay; Pereira, Felicidade Mota; Rovaris, Darcita Buerger; Fernandes, Sandra Bianchini; Ribeiro-Rodrigues, Rodrigo; Costa, Thais Oliveira; Sousa, Joaquim Cesar; Miyajima, Fabio; Delatorre, Edson; Gräf, Tiago; Bello, Gonzalo; Siqueira, Marilda Mendonça; Wallau, Gabriel Luz.
  • Dezordi FZ; Departamento de Entomologia, Instituto Aggeu Magalhães (IAM), FIOCRUZ-Pernambuco, Recife, Pernambuco, Brazil.
  • Resende PC; Núcleo de Bioinformática (NBI), Instituto Aggeu Magalhães (IAM), FIOCRUZ-Pernambuco, Recife, Pernambuco, Brazil.
  • Naveca FG; Laboratory of Respiratory Viruses and Measles (LVRS), Instituto Oswaldo Cruz, FIOCRUZ-Rio de Janeiro, Rio de Janeiro, Brazil.
  • do Nascimento VA; Laboratório de Ecologia de Doenças Transmissíveis na Amazônia (EDTA), Instituto Leônidas e Maria Deane, FIOCRUZ-Amazonas, Manaus, Amazonas, Brazil.
  • de Souza VC; Laboratório de Ecologia de Doenças Transmissíveis na Amazônia (EDTA), Instituto Leônidas e Maria Deane, FIOCRUZ-Amazonas, Manaus, Amazonas, Brazil.
  • Dias Paixão AC; Laboratório de Ecologia de Doenças Transmissíveis na Amazônia (EDTA), Instituto Leônidas e Maria Deane, FIOCRUZ-Amazonas, Manaus, Amazonas, Brazil.
  • Appolinario L; Laboratory of Respiratory Viruses and Measles (LVRS), Instituto Oswaldo Cruz, FIOCRUZ-Rio de Janeiro, Rio de Janeiro, Brazil.
  • Lopes RS; Laboratory of Respiratory Viruses and Measles (LVRS), Instituto Oswaldo Cruz, FIOCRUZ-Rio de Janeiro, Rio de Janeiro, Brazil.
  • da Fonseca Mendonça AC; Laboratory of Respiratory Viruses and Measles (LVRS), Instituto Oswaldo Cruz, FIOCRUZ-Rio de Janeiro, Rio de Janeiro, Brazil.
  • Barreto da Rocha AS; Laboratory of Respiratory Viruses and Measles (LVRS), Instituto Oswaldo Cruz, FIOCRUZ-Rio de Janeiro, Rio de Janeiro, Brazil.
  • Martins Venas TM; Laboratory of Respiratory Viruses and Measles (LVRS), Instituto Oswaldo Cruz, FIOCRUZ-Rio de Janeiro, Rio de Janeiro, Brazil.
  • Pereira EC; Laboratory of Respiratory Viruses and Measles (LVRS), Instituto Oswaldo Cruz, FIOCRUZ-Rio de Janeiro, Rio de Janeiro, Brazil.
  • Paiva MHS; Laboratory of Respiratory Viruses and Measles (LVRS), Instituto Oswaldo Cruz, FIOCRUZ-Rio de Janeiro, Rio de Janeiro, Brazil.
  • Docena C; Departamento de Entomologia, Instituto Aggeu Magalhães (IAM), FIOCRUZ-Pernambuco, Recife, Pernambuco, Brazil.
  • Bezerra MF; Núcleo de Ciências da Vida, Universidade Federal de Pernambuco (UFPE), Centro Acadêmico do Agreste, Caruaru, Pernambuco, Brazil.
  • Machado LC; Núcleo de Plataformas Tecnológicas (NPT), Instituto Aggeu Magalhães (IAM), FIOCRUZ-Pernambuco, Recife, Pernambuco, Brazil.
  • Salvato RS; Departamento de Microbiologia, Instituto Aggeu Magalhães (IAM), FIOCRUZ-Pernambuco, Recife, Pernambuco, Brazil.
  • Gregianini TS; Departamento de Entomologia, Instituto Aggeu Magalhães (IAM), FIOCRUZ-Pernambuco, Recife, Pernambuco, Brazil.
  • Martins LG; Laboratório Central de Saúde Pública, Centro Estadual de Vigilância em Saúde da Secretaria de Saúde do Estado do Rio Grande do Sul (LACEN/CEVS/SES-RS), Porto Alegre, Rio Grande do Sul, Brazil.
  • Pereira FM; Laboratório Central de Saúde Pública, Centro Estadual de Vigilância em Saúde da Secretaria de Saúde do Estado do Rio Grande do Sul (LACEN/CEVS/SES-RS), Porto Alegre, Rio Grande do Sul, Brazil.
  • Rovaris DB; Centro Estadual de Vigilância em Saúde da Secretaria de Saúde do Estado do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil.
  • Fernandes SB; Laboratório Central de Saúde Pública do Estado da Bahia (LACEN-BA), Salvador, Bahia, Brazil.
  • Ribeiro-Rodrigues R; Laboratório Central de Saúde Pública do Estado de Santa Catarina (LACEN-SC), Florianópolis, Santa Catarina, Brazil.
  • Costa TO; Laboratório Central de Saúde Pública do Estado de Santa Catarina (LACEN-SC), Florianópolis, Santa Catarina, Brazil.
  • Sousa JC; Laboratório Central de Saúde Pública do Estado do Espírito Santo (LACEN-ES), Vitória, Espírito Santo, Brazil.
  • Miyajima F; Analytical Competence Molecular Epidemiology Laboratory (ACME), FIOCRUZ-Ceará, Fortaleza, Ceará, Brazil.
  • Delatorre E; Analytical Competence Molecular Epidemiology Laboratory (ACME), FIOCRUZ-Ceará, Fortaleza, Ceará, Brazil.
  • Gräf T; Analytical Competence Molecular Epidemiology Laboratory (ACME), FIOCRUZ-Ceará, Fortaleza, Ceará, Brazil.
  • Bello G; Departamento de Biologia. Centro de Ciências Exatas, Naturais e da Saúde, Universidade Federal do Espírito Santo, Alegre, Espírito Santo, Brazil.
  • Siqueira MM; Instituto Gonçalo Moniz, FIOCRUZ-Bahia, Salvador, Bahia, Brazil.
  • Wallau GL; Laboratório de AIDS e Imunologia Molecular, Instituto Oswaldo Cruz, FIOCRUZ-Rio de Janeiro, Rio de Janeiro, Brazil.
Microb Genom ; 8(3)2022 03.
Article in English | MEDLINE | ID: covidwho-1746155
ABSTRACT
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has infected almost 200 million people worldwide by July 2021 and the pandemic has been characterized by infection waves of viral lineages showing distinct fitness profiles. The simultaneous infection of a single individual by two distinct SARS-CoV-2 lineages may impact COVID-19 disease progression and provides a window of opportunity for viral recombination and the emergence of new lineages with differential phenotype. Several hundred SARS-CoV-2 lineages are currently well phylogenetically defined, but two main factors have precluded major coinfection/codetection and recombination analysis thus far (i) the low diversity of SARS-CoV-2 lineages during the first year of the pandemic, which limited the identification of lineage defining mutations necessary to distinguish coinfecting/recombining viral lineages; and the (ii) limited availability of raw sequencing data where abundance and distribution of intrasample/intrahost variability can be accessed. Here, we assembled a large sequencing dataset from Brazilian samples covering a period of 18 May 2020 to 30 April 2021 and probed it for unexpected patterns of high intrasample/intrahost variability. This approach enabled us to detect nine cases of SARS-CoV-2 coinfection with well characterized lineage-defining mutations, representing 0.61 % of all samples investigated. In addition, we matched these SARS-CoV-2 coinfections with spatio-temporal epidemiological data confirming its plausibility with the cocirculating lineages at the timeframe investigated. Our data suggests that coinfection with distinct SARS-CoV-2 lineages is a rare phenomenon, although it is certainly a lower bound estimate considering the difficulty to detect coinfections with very similar SARS-CoV-2 lineages and the low number of samples sequenced from the total number of infections.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Superinfection / Coinfection / SARS-CoV-2 / COVID-19 Type of study: Randomized controlled trials Limits: Humans Country/Region as subject: South America / Brazil Language: English Year: 2022 Document Type: Article Affiliation country: Mgen.0.000751

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Superinfection / Coinfection / SARS-CoV-2 / COVID-19 Type of study: Randomized controlled trials Limits: Humans Country/Region as subject: South America / Brazil Language: English Year: 2022 Document Type: Article Affiliation country: Mgen.0.000751